The University of Helsinki, a key collaborator in our ongoing efforts, recently published an article that not only highlighted our project but also served as a powerful endorsement of its impact and potential for future advancements.
Gonçalo Barreto, PhD and Associate Professor at the University says is “thrilled to start working on the micro2MACRO project, which has the potential to make significant advances on the development of osteochondral tissue regeneration therapies. Our goal is to integrate genome editing with state-of-the-art 3D bioprinting modalities and demonstrate the functional advantage of genome-edited inflammation-resistant 3D bioprinted constructs in injured joint-like inflamed environments”.
Read the full article here.
